Boston life sciences and medical device leaders agreed that the change to a Trump administration could create a more ...

Ali Pashazadeh, CEO of the biotech consultancy Treehill Partners ... “I would be very cautious about being too optimistic ...

Longevity science is having a moment. An aging population is driving a global economy catering to those over 60 that is now ...

And so is Reeser, founder and CEO of a Wilmington startup that is bringing ... working with David and his OpiAID team,” said ...

With 10 days until Election Day, Republican former President Trump and Democratic Vice President Kamala Harris will both head to battleground Michigan for campaign events. Then Trump will go to ...

Starbucks earnings disappoint as it suspends guidance, McDonald’s quarter pounder linked to deadly E. coli outbreak, and more ...

For these reasons, I am planning to vote for change and support Donald Trump for President," Blackstone CEO Steve ... Woody Johnson, an heir to the Johnson and Johnson pharmaceutical fortune ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Edesa Biotech (EDSA) has released an update. Edesa Biotech’s CEO and Founder, Par Nijhawan, has made a strategic investment of up to $5 million in the company, demonstrating strong confidence in ...

TORONTO - Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has announced a new investment agreement involving its CEO, Dr. Par Nijhawan. Under the terms of the agreement, ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

Emergent BioSolutions raised its revenue guidance and dropped a going concern warning. Its CEO is billing this next chapter ...